Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
218.40
+0.20 (0.09%)
At close: Sep 25, 2025
0.09%
Market Cap193.60B
Revenue (ttm)75.86B
Net Income (ttm)23.50B
Shares Out886.45M
EPS (ttm)26.51
PE Ratio8.24
Forward PE8.15
Dividend11.00 (5.04%)
Ex-Dividend DateNov 24, 2024
Volume133,497
Average Volume236,897
Open219.00
Previous Close218.20
Day's Range218.10 - 219.30
52-Week Range198.90 - 234.10
Beta0.11
RSI37.96
Earnings DateOct 23, 2025

About DSE:SQURPHARMA

Square Pharmaceuticals PLC., together with its subsidiaries, manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally. The company offers pharmaceutical products comprising alimentary preparations, amoebocides, analgesics, anti-aphthous ulcer, anti-erectile dysfunction, anti-gout, anti-hyperkalemia, anti-osteoarthritis, anti-thyroid, anti-ulcerants, anthelmintics, antiallergies, antianemics, antiasthma, antibiotics, antidiabetics, antifibrinolytics, antihemorrhoidals, antihistamines, antiosteoporotics, antioxid... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 12,453
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SQURPHARMA
Full Company Profile

Financial Performance

In 2024, DSE:SQURPHARMA's revenue was 70.10 billion, an increase of 15.47% compared to the previous year's 60.71 billion. Earnings were 20.93 billion, an increase of 10.25%.

Financial Statements

News

There is no news available yet.